Drugs and Devices

FDA approves first generic versions of Cymbalta

On Dec. 11, the U.S. Food and Drug Administration (FDA) approved the first generic versions of Cymbalta (duloxetine delayed-release capsules). Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares